<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK535153" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK535153/" /><meta name="ncbi_pagename" content="AP-4-Associated Hereditary Spastic Paraplegia - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>AP-4-Associated Hereditary Spastic Paraplegia - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="AP-4-Associated Hereditary Spastic Paraplegia" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/12/13" /><meta name="citation_author" content="Darius Ebrahimi-Fakhari" /><meta name="citation_author" content="Robert Behne" /><meta name="citation_author" content="Alexandra K Davies" /><meta name="citation_author" content="Jennifer Hirst" /><meta name="citation_pmid" content="30543385" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK535153/" /><meta name="citation_keywords" content="Adaptor Protein Complex 4 Deficiency (AP-4 Deficiency)" /><meta name="citation_keywords" content="AP-4-Associated HSP" /><meta name="citation_keywords" content="AP-4 Deficiency Syndrome" /><meta name="citation_keywords" content="Adaptor Protein Complex 4 Deficiency (AP-4 Deficiency)" /><meta name="citation_keywords" content="AP-4-Associated HSP" /><meta name="citation_keywords" content="AP-4 Deficiency Syndrome" /><meta name="citation_keywords" content="AP4B1-Related AP-4 Deficiency (SPG47)" /><meta name="citation_keywords" content="AP4E1-Related AP-4 Deficiency (SPG51)" /><meta name="citation_keywords" content="AP4M1-Related AP-4 Deficiency (SPG50)" /><meta name="citation_keywords" content="AP4S1-Related AP-4 Deficiency (SPG52)" /><meta name="citation_keywords" content="AP-4 complex subunit beta-1" /><meta name="citation_keywords" content="AP-4 complex subunit epsilon-1" /><meta name="citation_keywords" content="AP-4 complex subunit mu-1" /><meta name="citation_keywords" content="AP-4 complex subunit sigma-1" /><meta name="citation_keywords" content="AP4B1" /><meta name="citation_keywords" content="AP4E1" /><meta name="citation_keywords" content="AP4M1" /><meta name="citation_keywords" content="AP4S1" /><meta name="citation_keywords" content="AP-4-Associated Hereditary Spastic Paraplegia" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="AP-4-Associated Hereditary Spastic Paraplegia" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Darius Ebrahimi-Fakhari" /><meta name="DC.Contributor" content="Robert Behne" /><meta name="DC.Contributor" content="Alexandra K Davies" /><meta name="DC.Contributor" content="Jennifer Hirst" /><meta name="DC.Date" content="2018/12/13" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK535153/" /><meta name="description" content="AP-4-associated hereditary spastic paraplegia (HSP), also known as AP-4 deficiency syndrome, is a group of neurodegenerative disorders characterized by a progressive, complex spastic paraplegia with onset typically in infancy or early childhood. Early-onset hypotonia evolves into progressive lower-extremity spasticity. The majority of children become non-ambulatory and usually wheelchair bound. Over time spasticity progresses to involve the upper extremities, resulting in a spastic tetraplegia. Associated complications include dysphagia, contractures, foot deformities, dysregulation of bladder and bowel function, and a pseudobulbar affect. About 50% of affected individuals have seizures. Postnatal microcephaly (usually in the -2SD to -3SD range) is common. All have developmental delay. Speech development is significantly impaired and many affected individuals remain nonverbal. Intellectual disability in older children is usually moderate to severe." /><meta name="og:title" content="AP-4-Associated Hereditary Spastic Paraplegia" /><meta name="og:type" content="book" /><meta name="og:description" content="AP-4-associated hereditary spastic paraplegia (HSP), also known as AP-4 deficiency syndrome, is a group of neurodegenerative disorders characterized by a progressive, complex spastic paraplegia with onset typically in infancy or early childhood. Early-onset hypotonia evolves into progressive lower-extremity spasticity. The majority of children become non-ambulatory and usually wheelchair bound. Over time spasticity progresses to involve the upper extremities, resulting in a spastic tetraplegia. Associated complications include dysphagia, contractures, foot deformities, dysregulation of bladder and bowel function, and a pseudobulbar affect. About 50% of affected individuals have seizures. Postnatal microcephaly (usually in the -2SD to -3SD range) is common. All have developmental delay. Speech development is significantly impaired and many affected individuals remain nonverbal. Intellectual disability in older children is usually moderate to severe." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK535153/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/ap4-def/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK535153/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8900D5DFC856E10000000002F70166.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK535153_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK535153_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ano5-md/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/fap/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK535153_"><span class="title" itemprop="name">AP-4-Associated Hereditary Spastic Paraplegia</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Adaptor Protein Complex 4 Deficiency (AP-4 Deficiency), AP-4-Associated HSP, AP-4 Deficiency Syndrome</div><p class="contrib-group"><span itemprop="author">Darius Ebrahimi-Fakhari</span>, MD, PhD, <span itemprop="author">Robert Behne</span>, <span itemprop="author">Alexandra K Davies</span>, PhD, and <span itemprop="author">Jennifer Hirst</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK535153_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK535153_ai__"><div class="contrib half_rhythm"><span itemprop="author">Darius Ebrahimi-Fakhari</span>, MD, PhD<div class="affiliation small">Boston Children's Hospital<br />Harvard Medical School<br />Boston, Massachusetts<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.dravrah.snerdlihc@irahkaf-imiharbe.suirad" class="oemail">ude.dravrah.snerdlihc@irahkaf-imiharbe.suirad</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Robert Behne</span><div class="affiliation small">Boston Children's Hospital<br />Harvard Medical School<br />Boston, Massachusetts<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.dravrah.snerdlihc@enheb.trebor" class="oemail">ude.dravrah.snerdlihc@enheb.trebor</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Alexandra K Davies</span>, PhD<div class="affiliation small">Cambridge Institute for Medical Research<br />University of Cambridge<br />Cambridge, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.mac@04dka" class="oemail">ku.ca.mac@04dka</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Jennifer Hirst</span>, PhD<div class="affiliation small">Cambridge Institute for Medical Research<br />University of Cambridge<br />Cambridge, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.mac@822hj" class="oemail">ku.ca.mac@822hj</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">December 13, 2018</span>.</p><p><em>Estimated reading time: 20 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="ap4-def.Summary" itemprop="description"><h2 id="_ap4-def_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>AP-4-associated hereditary spastic paraplegia (HSP), also known as AP-4 deficiency syndrome, is a group of neurodegenerative disorders characterized by a progressive, complex spastic paraplegia with onset typically in infancy or early childhood. Early-onset hypotonia evolves into progressive lower-extremity spasticity. The majority of children become non-ambulatory and usually wheelchair bound. Over time spasticity progresses to involve the upper extremities, resulting in a spastic tetraplegia. Associated complications include dysphagia, contractures, foot deformities, dysregulation of bladder and bowel function, and a pseudobulbar affect. About 50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have seizures. Postnatal microcephaly (usually in the -2SD to -3SD range) is common. All have developmental delay. Speech development is significantly impaired and many affected individuals remain nonverbal. Intellectual disability in older children is usually moderate to severe.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of AP-4-associated HSP is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in one of four genes: <i>AP4B1</i>, <i>AP4E1</i>, <i>AP4M1</i>, or <i>AP4S1.</i></p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Management by an interdisciplinary team (including a neurologist, clinical geneticist, developmental specialist, orthopedic surgeon/physiatrist, physical therapist, occupational therapist, and a speech and language pathologist) to address spasticity/weakness, secondary musculoskeletal findings, developmental delay and intellectual disability, seizures, and swallowing and feeding difficulties.</p><p><i>Surveillance:</i> Evaluation every six to 12 months by an interdisciplinary team to assess disease progression and to maximize ambulation and communication skills while reducing the effect of other manifestations (e.g., musculoskeletal complications, dysphagia / feeding difficulties, and seizures).</p></div><div><h4 class="inline">Genetic counseling.</h4><p>AP-4-associated HSP is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Once the AP-4-associated HSP-causing pathogenic variants have been identified in an affected family member, <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> for at-risk relatives, prenatal testing for a pregnancy at increased risk, and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="ap4-def.GeneReview_Scope"><h2 id="_ap4-def_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="ap4-def.Td" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK535153/table/ap4-def.Td/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ap4-def.Td_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ap4-def.Td_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AP-4-Associated Hereditary Spastic Paraplegia: Included Disorders&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_ap4-def.Td_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div><i>AP4B1</i>-related AP-4 deficiency (SPG47)</div></li><li class="half_rhythm"><div><i>AP4E1</i>-related AP-4 deficiency (SPG51)</div></li><li class="half_rhythm"><div><i>AP4M1</i>-related AP-4 deficiency (SPG50)</div></li><li class="half_rhythm"><div><i>AP4S1</i>-related AP-4 deficiency (SPG52)</div></li></ul></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="ap4-def.TF.d.1"><p class="no_margin">Genetic loci for HSP are designated "SPG" (for "<i>s</i>pastic <i>p</i>araple<i>g</i>ia") followed by a number indicating the order of their discovery [<a class="bk_pop" href="#ap4-def.REF.fink.2013.307">Fink 2013</a>].</p></div></dd></dl></div></div></div></div><div id="ap4-def.Diagnosis"><h2 id="_ap4-def_Diagnosis_">Diagnosis</h2><p>Formal diagnostic criteria for AP-4-associated hereditary spastic paraplegia (HSP) have not been established.</p><div id="ap4-def.Suggestive_Findings"><h3>Suggestive Findings</h3><p>AP-4-associated HSP <b>should be suspected</b> in individuals with the following clinical findings and characteristic brain imaging findings [<a class="bk_pop" href="#ap4-def.REF.verkerk.2009.40">Verkerk et al 2009</a>, <a class="bk_pop" href="#ap4-def.REF.abou_jamra.2011.788">Abou Jamra et al 2011</a>, <a class="bk_pop" href="#ap4-def.REF.morenodeluca.2011.141">Moreno-De-Luca et al 2011</a>, <a class="bk_pop" href="#ap4-def.REF.ebrahimifakhari.2018.311">Ebrahimi-Fakhari et al 2018</a>].</p><div id="ap4-def.Clinical_Findings"><h4>Clinical Findings</h4><p>Characteristic findings:</p><ul><li class="half_rhythm"><div>Progressive spastic paraplegia with progression to tetraplegia in the later stages (94%, 58/62)&#x000a0;*</div></li><li class="half_rhythm"><div>Early-onset developmental delay (100%, 68/68)&#x000a0;*</div><ul><li class="half_rhythm"><div>Delayed motor milestones (100%, 54/54)&#x000a0;*</div></li><li class="half_rhythm"><div>Failure to achieve or loss of independent ambulation (93%, 41/44)&#x000a0;*</div></li><li class="half_rhythm"><div>Impaired or absent speech development (98%, 51/52)&#x000a0;*</div></li></ul></li><li class="half_rhythm"><div>Neonatal/infantile hypotonia (usually mild) (100%, 41/41)&#x000a0;*</div></li><li class="half_rhythm"><div>Postnatal microcephaly (77%, 47/61) (usually in -2SD to -3SD range)&#x000a0;*</div></li><li class="half_rhythm"><div>Early-onset seizures including frequent febrile seizures (42%, 25/59)&#x000a0;*</div></li></ul><p>Less frequent findings:</p><ul><li class="half_rhythm"><div>Short statue (65%, 17/26)&#x000a0;*</div></li><li class="half_rhythm"><div>Nonspecific <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> facial features (82%, 41/50)&#x000a0;*</div></li><li class="half_rhythm"><div>Episodes of stereotypic laughter [<a class="bk_pop" href="#ap4-def.REF.ebrahimifakhari.2018.311">Ebrahimi-Fakhari et al 2018</a>]</div></li><li class="half_rhythm"><div>Foot deformities (i.e., clubfoot)</div></li></ul></div><div id="ap4-def.Brain_Imaging_Findings"><h4>Brain Imaging Findings</h4><p>Characteristic findings:</p><ul><li class="half_rhythm"><div>Thinning of the corpus callosum (with prominent thinning of the posterior parts) (88%, 37/42)&#x000a0;*</div></li><li class="half_rhythm"><div>Delayed myelination and nonspecific loss of the periventricular white matter (69%, 29/42)&#x000a0;*</div></li><li class="half_rhythm"><div>Ex-vacuo ventriculomegaly, often with prominent enlargement of the posterior horns of the lateral ventricles (60%, 24/40)&#x000a0;*</div></li></ul><p>Less frequent findings:</p><ul><li class="half_rhythm"><div>Cortical atrophy and cerebellar atrophy</div></li><li class="half_rhythm"><div>Brain iron accumulation [<a class="bk_pop" href="#ap4-def.REF.vill.2017.797">Vill et al 2017</a>, <a class="bk_pop" href="#ap4-def.REF.roubertie.2018.e217">Roubertie et al 2018</a>]</div></li></ul><p>*&#x000a0;Data from the International Registry and Natural History Study of Adaptor-Protein 4-Related Hereditary Spastic Paraplegia (updated 5-20-18)</p></div></div><div id="ap4-def.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of AP-4-associated HSP <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in one of four genes: <i>AP4B1</i>, <i>AP4E1</i>, <i>AP4M1</i>, or <i>AP4S1</i> (see <a class="figpopup" href="/books/NBK535153/table/ap4-def.T.molecular_genetic_testing_used/?report=objectonly" target="object" rid-figpopup="figap4defTmoleculargenetictestingused" rid-ob="figobap4defTmoleculargenetictestingused">Table 1</a>).</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (typically <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>). Gene-targeted testing requires that the clinician determine which gene(s) are likely involved, whereas genomic testing does not.</p><p><b>Developmental delay / intellectual disability, spasticity, epilepsy, or microcephaly multigene panels</b> that include <i>AP4B1</i>, <i>AP4E1</i>, <i>AP4M1</i>, <i>AP4S1</i>, and other genes of interest (see <a href="#ap4-def.Differential_Diagnosis">Differential Diagnosis</a>) are most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. Of note, given the rarity of AP-4-associated HSP, some panels for developmental delay / intellectual disability and/or spasticity and/or epilepsy and/or microcephaly may not include this gene. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>Comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option when the clinician cannot determine which <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> best fits the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's clinical findings. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible. If <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a> (when clinically available) may be considered to detect (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="ap4-def.T.molecular_genetic_testing_used" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in AP-4 Associated Hereditary Spastic Paraplegia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK535153/table/ap4-def.T.molecular_genetic_testing_used/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ap4-def.T.molecular_genetic_testing_used_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1,&#x000a0;2</sup></th><th id="hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_1_2" style="text-align:left;vertical-align:middle;">Proportion of AP-4 Deficiency Attributed to Pathogenic Variants in Gene&#x000a0;<sup>3</sup></th><th id="hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>4</sup> Detectable by Method&#x000a0;<sup>3</sup></th></tr><tr><th headers="hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_1_3" id="hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>5</sup></th><th headers="hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_1_3" id="hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></th></tr></thead><tbody><tr><td headers="hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AP4B1</i></td><td headers="hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~40% (32/80 probands)</td><td headers="hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_1_3 hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100% (25/25 probands)</td><td headers="hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_1_3 hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported</td></tr><tr><td headers="hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AP4E1</i></td><td headers="hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~14% (11/80 probands)</td><td headers="hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_1_3 hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">70% (7/10 probands)</td><td headers="hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_1_3 hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">30% (3/10 probands)</td></tr><tr><td headers="hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AP4M1</i></td><td headers="hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~31% (25/80 probands)</td><td headers="hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_1_3 hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100% (22/22 probands)</td><td headers="hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_1_3 hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported</td></tr><tr><td headers="hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AP4S1</i></td><td headers="hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~15% (12/80 probands)</td><td headers="hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_1_3 hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100% (11/11 probands)</td><td headers="hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_1_3 hd_h_ap4-def.T.molecular_genetic_testing_used_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="ap4-def.TF.1.1"><p class="no_margin">Genes are listed in alphabetic order.</p></div></dd><dt>2. </dt><dd><div id="ap4-def.TF.1.2"><p class="no_margin">See <a href="/books/NBK535153/#ap4-def.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>3. </dt><dd><div id="ap4-def.TF.1.3"><p class="no_margin">International Registry and Natural History Study of Adaptor-Protein 4-Related HSP (updated 5-20-18)</p></div></dd><dt>4. </dt><dd><div id="ap4-def.TF.1.4"><p class="no_margin">See <a href="#ap4-def.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>5. </dt><dd><div id="ap4-def.TF.1.5"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>6. </dt><dd><div id="ap4-def.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd></dl></div></div></div></div></div><div id="ap4-def.Clinical_Characteristics"><h2 id="_ap4-def_Clinical_Characteristics_">Clinical Characteristics</h2><div id="ap4-def.Clinical_Description"><h3>Clinical Description</h3><p>AP-4-associated hereditary spastic paraplegia (HSP) is characterized by complex spastic paraplegia in all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals reported to date. Onset is usually before age one year. Infants manifest hypotonia, microcephaly, and delayed developmental milestones; some also have seizures. The early-childhood hypotonia evolves into progressive lower-extremity weakness and spasticity with pyramidal signs (plantar extension and hyperreflexia). Over time children often become non-ambulatory and ultimately require mobility aids / wheelchairs. Spasticity progresses to involve the upper extremities, resulting in spastic tetraplegia.</p><p>Associated complications include dysphagia, contractures secondary to progressive spasticity, foot deformities, and dysregulation of bladder and bowel function.</p><p>Microcephaly becomes evident in infancy in the majority and is often in the -2 SD to -3 SD range.</p><p>Developmental delay is universal. Delayed motor milestones are often the presenting manifestation:</p><ul><li class="half_rhythm"><div>Rolling (mean age: 6.5 months)</div></li><li class="half_rhythm"><div>Sitting (mean age: 10.2 months)</div></li><li class="half_rhythm"><div>Crawling (mean age: 22.8 months)</div></li></ul><p>Only a subset of children achieve independent walking (mean age: 33.5 months), a skill that is often lost as the disease progresses [Data from the International Registry and Natural History Study of AP-4-Related HSP; updated 5-20-18].</p><p>Speech and language development is significantly impaired and many <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals remain nonverbal. Intellectual disability in older children is usually moderate to severe.</p><p>Seizures often occur in the first two years of life; about 50% of individuals with AP-4-associated HSP have a diagnosis of epilepsy. Seizure types include focal-onset seizures (often with secondary generalization) as well as primary generalized seizures. Status epilepticus has been reported in a significant subset of patients. About 50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, including individuals with and without epilepsy, have seizures in the setting of fever. In general, seizures become less frequent with age and are often well controlled with standard antiepileptic drugs.</p><p>Episodes of stereotypic laughter, perhaps indicating a pseudobulbar affect, are a characteristic finding in a subset of individuals [<a class="bk_pop" href="#ap4-def.REF.ebrahimifakhari.2018.311">Ebrahimi-Fakhari et al 2018</a>].</p><p>Less frequent clinical manifestations include short stature, nonspecific <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> facial features, optic nerve atrophy, dystonia, and ataxia.</p><p>To date, uncomplicated hereditary spastic paraplegia, a pure spastic paraplegia without other neurological manifestations, has not been reported in individuals with AP-4 deficiency.</p><p><b>Prognosis.</b> Natural history data are not currently available. The oldest reported individuals are young adults.</p></div><div id="ap4-def.Phenotype_Correlations_by_Gene"><h3>Phenotype Correlations by Gene</h3><p>AP-4-associated HSP is caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants in one of the four genes that encode subunits of the AP-4 complex (&#x003b2;4, &#x003b5;, &#x003bc;4, &#x003c3;4). Because loss of any one subunit renders the entire complex nonfunctional, biallelic loss-of-function variants in any one of the four genes cause the same molecular defect &#x02013; loss of AP-4 complex function &#x02013; and the same <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Brain iron accumulation has been reported in one family with <i>AP4M1</i>-related AP-4 deficiency syndrome [<a class="bk_pop" href="#ap4-def.REF.roubertie.2018.e217">Roubertie et al 2018</a>] and one individual with <i>AP4S1</i>-related AP-4 deficiency syndrome [<a class="bk_pop" href="#ap4-def.REF.vill.2017.797">Vill et al 2017</a>]. Given the rarity of this finding and a potential age bias, it is unknown if brain iron accumulation is a feature of AP-4-associated HSP regardless of cause.</p></div><div id="ap4-def.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have been reported for any of the four genes known to cause AP-4-associated HSP (<i>AP4B1</i>, <i>AP4E1</i>, <i>AP4M1</i>, <i>AP4S1</i>).</p></div><div id="ap4-def.Nomenclature"><h3>Nomenclature</h3><div id="ap4-def.T.other_terms_used_to_refer_to_a" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Other Terms Used to Refer to AP-4-Associated Hereditary Spastic Paraplegia Subtypes</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK535153/table/ap4-def.T.other_terms_used_to_refer_to_a/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ap4-def.T.other_terms_used_to_refer_to_a_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ap4-def.T.other_terms_used_to_refer_to_a_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Subtype</th><th id="hd_h_ap4-def.T.other_terms_used_to_refer_to_a_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Terms</th></tr></thead><tbody><tr><td headers="hd_h_ap4-def.T.other_terms_used_to_refer_to_a_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AP4B1</i>-related AP-4 deficiency syndrome</td><td headers="hd_h_ap4-def.T.other_terms_used_to_refer_to_a_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hereditary spastic paraplegia type 47</div></li><li class="half_rhythm"><div>Spastic paraplegia type 47 (SPG47&#x000a0;<sup>1</sup>)</div></li><li class="half_rhythm"><div><i>AP4B1</i>-related hereditary spastic paraplegia (HSP-AP4B1)</div></li></ul></td></tr><tr><td headers="hd_h_ap4-def.T.other_terms_used_to_refer_to_a_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AP4E1</i>-related AP-4 deficiency syndrome</td><td headers="hd_h_ap4-def.T.other_terms_used_to_refer_to_a_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hereditary spastic paraplegia type 51</div></li><li class="half_rhythm"><div>Spastic paraplegia type 51 (SPG51)</div></li><li class="half_rhythm"><div><i>AP4E1</i>-related hereditary spastic paraplegia (HSP-AP4E1)</div></li></ul></td></tr><tr><td headers="hd_h_ap4-def.T.other_terms_used_to_refer_to_a_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AP4M1</i>-related AP-4 deficiency syndrome</td><td headers="hd_h_ap4-def.T.other_terms_used_to_refer_to_a_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hereditary spastic paraplegia type 50</div></li><li class="half_rhythm"><div>Spastic paraplegia type 50 (SPG50)</div></li><li class="half_rhythm"><div><i>AP4M1</i>-related hereditary spastic paraplegia (HSP-AP4M1)</div></li></ul></td></tr><tr><td headers="hd_h_ap4-def.T.other_terms_used_to_refer_to_a_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AP4S1</i>-related AP-4 deficiency syndrome</td><td headers="hd_h_ap4-def.T.other_terms_used_to_refer_to_a_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hereditary spastic paraplegia type 52</div></li><li class="half_rhythm"><div>Spastic paraplegia type 52 (SPG52)</div></li><li class="half_rhythm"><div><i>AP4S1</i>-related hereditary spastic paraplegia (HSP-AP4S1)</div></li></ul></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="ap4-def.TF.2.1"><p class="no_margin">Genetic loci for HSP are designated "SPG" (for "<i>s</i>pastic <i>p</i>araple<i>g</i>ia") followed by a number indicating the order of their discovery [<a class="bk_pop" href="#ap4-def.REF.fink.2013.307">Fink 2013</a>].</p></div></dd></dl></div></div></div><p>Recommendations for the nomenclature of genetic movement disorders, including AP-4-associated HSP, have been published [<a class="bk_pop" href="#ap4-def.REF.marras.2016.436">Marras et al 2016</a>].</p></div><div id="ap4-def.Prevalence"><h3>Prevalence</h3><p>AP-4-associated HSP is rare. To date about 80 individuals are known; all have been included in the International Registry and Natural History Study of AP-4-Related Hereditary Spastic Paraplegia (updated 5-20-18).</p><p>Families with AP-4-associated HSP have been reported from North America, Europe, the Middle East, and the Indian subcontinent.&#x000a0;*</p><p>About two thirds of individuals with AP-4-associated HSP have <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> parents;&#x000a0;* however, this could be the result of ascertainment bias, as initial reports have mainly focused on families from countries with high rates of <a class="def" href="/books/n/gene/glossary/def-item/consanguinity/">consanguinity</a> [<a class="bk_pop" href="#ap4-def.REF.verkerk.2009.40">Verkerk et al 2009</a>, <a class="bk_pop" href="#ap4-def.REF.abou_jamra.2011.788">Abou Jamra et al 2011</a>, <a class="bk_pop" href="#ap4-def.REF.morenodeluca.2011.141">Moreno-De-Luca et al 2011</a>]. More recently, AP-4-associated HSP has been reported in populations with low rates of consanguinity [<a class="bk_pop" href="#ap4-def.REF.ebrahimifakhari.2018.311">Ebrahimi-Fakhari et al 2018</a>].</p><p>*&#x000a0;International Registry and Natural History Study of AP-4-Related HSP</p></div></div><div id="ap4-def.Genetically_Related_Allelic_Diso"><h2 id="_ap4-def_Genetically_Related_Allelic_Diso_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>AP4B1</i>, <i>AP4S1</i>, or <i>AP4M1</i>.</p><p>Heterozygous variants in <i>AP4E1</i> have been described in individuals with persistent stuttering [<a class="bk_pop" href="#ap4-def.REF.raza.2015.715">Raza et al 2015</a>].</p></div><div id="ap4-def.Differential_Diagnosis"><h2 id="_ap4-def_Differential_Diagnosis_">Differential Diagnosis</h2><p>Many of the initial manifestations of AP-4-associated HSP are nonspecific and may resemble other disorders characterized by spasticity, developmental delay / intellectual disability, and a thin corpus callosum. Many children with AP-4-associated HSP are diagnosed with cerebral palsy before genetic testing is obtained.</p><p><a class="figpopup" href="/books/NBK535153/table/ap4-def.T.distinguishing_clinical_featur/?report=objectonly" target="object" rid-figpopup="figap4defTdistinguishingclinicalfeatur" rid-ob="figobap4defTdistinguishingclinicalfeatur">Table 3</a> summarizes the features that distinguish the disorders most likely considered in the differential diagnosis from AP-4-associated HSP.</p><div id="ap4-def.T.distinguishing_clinical_featur" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Distinguishing Clinical Features of Hereditary Disorders to Consider in the Differential Diagnosis of AP-4-Associated HSP</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK535153/table/ap4-def.T.distinguishing_clinical_featur/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ap4-def.T.distinguishing_clinical_featur_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene(s)&#x000a0;<sup>1</sup><br />(Locus/Disorder)</th><th id="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing Clinical Features of the Differential Diagnosis Disorder</th></tr></thead><tbody><tr><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AMPD2</i><br />(SPG63)</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Central visual impairment</div></li><li class="half_rhythm"><div>Cerebellar hypoplasia/atrophy</div></li></ul></td></tr><tr><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ARSI</i><br />(SPG66)</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Peripheral neuropathy</td></tr><tr><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>C12orf65</i><br />(SPG55)</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Optic atrophy</div></li><li class="half_rhythm"><div>Motor sensory neuropathy</div></li></ul></td></tr><tr><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CYP2U1</i><br />(SPG56)</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Basal ganglia calcification</td></tr><tr><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DDHD2</i><br />(SPG54)</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Optic-nerve hypoplasia is more common.</td></tr><tr><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FA2H</i><br />(SPG35; <a href="/books/n/gene/fahn/">fatty acid hydroxylase-associated neurodegeneration</a>)</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Later onset</div></li><li class="half_rhythm"><div>Brain iron accumulation is more common.</div></li></ul></td></tr><tr><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GBA2</i><br />(SPG46)</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Congenital cataracts</div></li><li class="half_rhythm"><div>Hearing loss</div></li><li class="half_rhythm"><div>Neuropathy</div></li></ul></td></tr><tr><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GJC2</i><br />(SPG44)</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Later onset</td></tr><tr><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>L1CAM</i><br />(SPG1; <a href="/books/n/gene/l1cam/">L1 syndrome</a>)</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Adducted thumbs</td></tr><tr><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NT5C2</i><br />(SPG45 [SPG65])</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Optic atrophy is more common.</td></tr><tr><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PGAP1</i><br />(SPG67)</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Tremor</td></tr><tr><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RUSC2</i><br />(<i>RUSC2</i>-associated ID; OMIM <a href="https://omim.org/entry/617773" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">617773</a>)</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Described in 1 family only</td></tr><tr><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SPG11</i><br />(<a href="/books/n/gene/spg11/">spastic paraplegia 11</a>)</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Later onset</div></li><li class="half_rhythm"><div>Distal amyotrophy</div></li><li class="half_rhythm"><div>Pigmentary retinopathy</div></li><li class="half_rhythm"><div>Ataxia</div></li><li class="half_rhythm"><div>Parkinsonism</div></li><li class="half_rhythm"><div>Ears of the lynx sign on MRI</div></li></ul></td></tr><tr><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SPG21</i><br />(SPG21)</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Onset in young adulthood</div></li><li class="half_rhythm"><div>Cerebellar signs</div></li></ul></td></tr><tr><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TECPR2</i><br />(SPG49)</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Autonomic-sensory neuropathy</div></li><li class="half_rhythm"><div>Apneas/chronic respiratory disease</div></li><li class="half_rhythm"><div>Dysmorphism</div></li></ul></td></tr><tr><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ZFR</i><br />(SPG71)</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Described in 1 individual only</td></tr><tr><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ZFYVE26</i><br />(SPG15)</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ap4-def.T.distinguishing_clinical_featur_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Later onset</div></li><li class="half_rhythm"><div>Pigmentary retinopathy</div></li><li class="half_rhythm"><div>Neuropathy</div></li><li class="half_rhythm"><div>Parkinsonism</div></li></ul></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note: See <a href="/books/n/gene/hsp/">Hereditary Spastic Paraplegia Overview</a> for a general discussion of this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p></div></dd><dt></dt><dd><div><p class="no_margin">AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; ID = intellectual disability; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; SPG = spastic paraplegia; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="ap4-def.TF.3.1"><p class="no_margin">Genes are in alphabetic order.</p></div></dd></dl></div></div></div><p><b>Other hereditary disorders to consider</b> in the differential diagnosis of AP-4-associated HSP include the leukodystrophies (see <a href="/books/n/gene/leukodys-ov/">Leukodystrophy Overview</a>) and certain inborn errors of metabolism (particularly important are treatable conditions such as dopa-responsive dystonia (see <a href="/books/n/gene/drd/">GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia</a>).</p></div><div id="ap4-def.Management"><h2 id="_ap4-def_Management_">Management</h2><div id="ap4-def.Evaluations_Following_Initial_Di"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with AP-4-associated hereditary spastic paraplegia (HSP), the evaluations summarized in <a class="figpopup" href="/books/NBK535153/table/ap4-def.T.recommended_evaluations_follow/?report=objectonly" target="object" rid-figpopup="figap4defTrecommendedevaluationsfollow" rid-ob="figobap4defTrecommendedevaluationsfollow">Table 4</a> (if not performed as part of the evaluation that led to the diagnosis) are recommended.</p><div id="ap4-def.T.recommended_evaluations_follow" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Individuals with AP-4-Associated HSP</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK535153/table/ap4-def.T.recommended_evaluations_follow/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ap4-def.T.recommended_evaluations_follow_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmologic evaluation</td><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>To assess visual acuity</div></li><li class="half_rhythm"><div>To perform fundoscopic exam for evidence of optic atrophy</div></li></ul></td></tr><tr><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neurologic evaluation</td><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To incl brain MRI. Consider EEG if seizures are a concern.</td></tr><tr><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastrointestinal/</b><br /><b>Feeding</b></td><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gastroenterology / nutrition / feeding team evaluation</td><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>To incl evaluation of aspiration risk &#x00026; nutritional status</div></li><li class="half_rhythm"><div>Consider evaluation for gastric tube placement in patients w/dysphagia &#x00026;/or aspiration risk.</div></li></ul></td></tr><tr><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Pulmonary</b></td><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pulmonary evaluation</td><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To incl evaluation of aspiration risk &#x00026; secretion management</td></tr><tr><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Genitourinary</b></td><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neuro-urologic evaluation</td><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To incl urodynamic testing</td></tr><tr><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Orthopedics / physiatry / PT / OT evaluation</td><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To incl PT/OT evaluation &#x00026; assessment for mobility, activities of daily living, contractures, scoliosis, &#x00026; foot deformities</td></tr><tr><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Referral to pediatric pain specialist</td><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">For those who have pain due to deforming joint contractures</td></tr><tr><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/</b><br /><b>Other</b></td><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental assessment</td><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>To incl motor, adaptive, cognitive, &#x00026; speech/language evaluation</div></li><li class="half_rhythm"><div>Evaluation for early intervention / special education</div></li></ul></td></tr><tr><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To incl <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a></td></tr><tr><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Family supports/resources</td><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Community or online resources e.g., Parent to Parent</div></li><li class="half_rhythm"><div>Social work involvement for parental support</div></li><li class="half_rhythm"><div>Home nursing referral if needed</div></li></ul></td></tr><tr><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Referral to palliative care</td><td headers="hd_h_ap4-def.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">When deemed appropriate by family &#x00026; health care providers</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">OT = occupational therapy; PT = physical therapy</p></div></dd></dl></div></div></div></div><div id="ap4-def.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>At present, no treatment prevents, halts, or reverses neuronal degeneration in AP-4-associated HSP. Treatment is directed at reducing symptoms and preventing secondary complications.</p><div id="ap4-def.T.treatment_of_manifestations_in" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with AP-4-Associated HSP</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK535153/table/ap4-def.T.treatment_of_manifestations_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ap4-def.T.treatment_of_manifestations_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation/<br />Concern</th><th id="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Feeding difficulties &#x00026; growth failure</b></td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Nutritional supplementation</div></li><li class="half_rhythm"><div>G-tube feeds</div></li></ul></td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Referral to nutritionist</div></li><li class="half_rhythm"><div>Gastrostomy feeding &#x02193; aspiration risk / provides a reliable route for medication / can improve nutritional status.</div></li></ul></td></tr><tr><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dysphagia</b></td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">G-tube feeds</td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dysphagia-associated aspiration may &#x02192; recurrent aspiration pneumonia.</td></tr><tr><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Sialorrhea</b></td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Anticholinergic drugs</div></li><li class="half_rhythm"><div>Botulinum toxin injections</div></li><li class="half_rhythm"><div>Surgery</div></li></ul></td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Management by an interdisciplinary aerodigestive team</td></tr><tr><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Aspiration</b></td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Management of secretions</div></li><li class="half_rhythm"><div>G-tube feeds</div></li></ul></td></tr><tr><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Pulmonary complications</b></td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Minimize aspiration risk (see above)</div></li><li class="half_rhythm"><div>Pulmonary toilet</div></li></ul></td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Aspiration, pulmonary infections, restrictive lung disease secondary to scoliosis &#x00026; spasticity</div></li><li class="half_rhythm"><div>Referral to pulmonologist</div></li></ul></td></tr><tr><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Bowel dysfunction, chronic constipation, gastroesophageal reflux</b></td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Stool softeners, prokinetics, osmotic agents, or laxatives as needed</div></li><li class="half_rhythm"><div>Proton pump inhibitors, histamine receptor antagonists, or antacids as needed</div></li><li class="half_rhythm"><div>Consideration of fundoplication in refractory cases</div></li></ul></td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Referral to gastroenterologist</td></tr><tr><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Delayed speech development</b></td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Speech &#x00026; language therapy</td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">See <a href="#ap4-def.Developmental_Delay__Intellectua">Developmental Delay / Intellectual Disability Management Issues</a>.</td></tr><tr><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Delayed motor development</b></td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Physiotherapy</div></li><li class="half_rhythm"><div>Occupational therapy</div></li></ul></td></tr><tr><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Spasticity/</b><br /><b>Weakness/</b><br /><b>Hypotonia</b></td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Physiotherapy</div></li><li class="half_rhythm"><div>Antispasticity medications such as oral or intrathecal baclofen</div></li><li class="half_rhythm"><div>Botulinum toxin injections</div></li><li class="half_rhythm"><div>Surgical treatment</div></li></ul></td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Progression of contractures, scoliosis, &#x00026; foot deformities may be delayed w/regular physiotherapy &#x00026; antispastic medications.</div></li><li class="half_rhythm"><div>Consider need for positioning and mobility devices.</div></li><li class="half_rhythm"><div>Monitor skin integrity.</div></li></ul></td></tr><tr><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Contractures</td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Physical therapy, referral to orthopedic surgery</td></tr><tr><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Scoliosis</td></tr><tr><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Foot deformities</td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Physical therapy, ankle-foot orthoses, referral to orthopedic surgery</td></tr><tr><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Urinary urgency</b></td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anticholinergic drugs</td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Referral to urologist</td></tr><tr><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Epilepsy</b></td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard antiepileptic drugs</td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Most patients respond to standard antiepileptic therapy.&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Osteopenia</b></td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Vitamin D &#x00026; calcium supplementation</td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td></tr><tr><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Routine health care</b></td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard immunizations per local guidelines</td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Family/</b><br /><b>Community</b></td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Ensure appropriate social work involvement to connect families w/local resources &#x00026; support.</div></li><li class="half_rhythm"><div>Ensure care coordination to manage multiple subspecialty appointments, equipment, medications, &#x00026; supplies.</div></li></ul></td><td headers="hd_h_ap4-def.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ongoing assessment for need of palliative care involvement &#x00026;/or home nursing.</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="ap4-def.TF.5.1"><p class="no_margin">Education of parents regarding common seizure presentations is appropriate. For information on non-medical interventions and coping strategies for parents or caregivers of children diagnosed with epilepsy, see <a href="http://www.epilepsy.com/sites/core/files/atoms/files/English_Toolkit_updated%202014.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Epilepsy &#x00026; My Child Toolkit</a>.</p></div></dd></dl></div></div></div><div id="ap4-def.Developmental_Delay__Intellectua"><h4>Developmental Delay / Intellectual Disability Management Issues</h4><p>The following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States; standard recommendations may vary from country to country.</p><p><b>Ages 0-3 years.</b> Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy as well as infant mental health services, special educators, and sensory-impairment specialists. In the US, early intervention is a federally funded program available in all states; it provides in-home services to target individual therapy needs.</p><p><b>Ages 3-5 years.</b> In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed for those who qualify based on established motor, language, social, and/or cognitive delay. The early intervention program typically assists with this transition. Developmental preschool is center based; however, for children too medically unstable to attend, home-based services are provided.</p><p><b>Ages 5-21 years.</b> IEP services:</p><ul><li class="half_rhythm"><div>In the US, an IEP based on the individual's level of function should be developed by the local public school district and will dictate specially designed instruction/related services.</div></li><li class="half_rhythm"><div>IEP services will be reviewed annually to determine if any changes are needed.</div></li><li class="half_rhythm"><div>As required by special education law, children should be in the least restrictive environment at school and included in general education as much as possible and when appropriate.</div></li><li class="half_rhythm"><div>Vision consultants should be a part of the child's IEP team to support access to academic material if the child has visual impairment.</div></li><li class="half_rhythm"><div>PT, OT, and speech services will be provided in the IEP to the extent that the need affects the child's access to academic material.</div></li><li class="half_rhythm"><div>As a child enters adolescence, an educational transition plan should be discussed and incorporated into the IEP. For those receiving IEP services, the public school district is required to provide services until age 21.</div></li></ul><p>Discussion about transition plans including financial and medical arrangements should begin at age 12 years. Developmental pediatricians can provide assistance with transition to adulthood.</p><p><b>All ages.</b> Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies and to support parents in maximizing quality of life.</p><p>Consideration of private supportive therapies based on the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's needs is recommended. Specific recommendations regarding type of therapy can be made by a developmental pediatrician.</p><p>In the US:</p><ul><li class="half_rhythm"><div>Developmental Disabilities Administration (DDA) enrollment is recommended. DDA is a public agency that provides services and support to qualified individuals. Eligibility differs by state but is typically determined by diagnosis and/or associated cognitive/adaptive disabilities.</div></li><li class="half_rhythm"><div>Families with limited income and resources may also qualify for supplemental security income (SSI) for their child with a disability.</div></li></ul></div><div id="ap4-def.Motor_Dysfunction"><h4>Motor Dysfunction</h4><p><b>Gross motor dysfunction</b></p><ul><li class="half_rhythm"><div>Physical therapy is recommended to maximize mobility.</div></li><li class="half_rhythm"><div>Consider use of durable medical equipment and positioning devices as needed (e.g., wheelchairs, walkers, bath chairs, orthotics, adaptive strollers).</div></li></ul><p><b>Fine motor dysfunction.</b> Occupational therapy is recommended for difficulty with fine motor skills that affect adaptive function such as feeding, grooming, dressing, and writing.</p><p><b>Oral-motor dysfunction</b> should be reassessed in regular intervals and clinical feeding evaluations and/or radiographic swallowing studies should be obtained for choking/gagging during feeds, poor weight gain, frequent respiratory illnesses, or feeding refusal that is not otherwise explained. Feeds can be thickened or chilled to minimize feeding problems; when severe feeding dysfunction is present, a gastrostomy tube may be necessary. Assuming that the individual is safe to eat by mouth, feeding therapy, typically from an occupational or speech therapist, can be helpful to improve coordination or sensory-related feeding issues.</p><p><b>Communication issues.</b> Consider evaluation for alternative means of communication (e.g., <a href="http://www.asha.org/NJC/AAC/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Augmentative and Alternative Communication</a> [AAC]) for individuals who have expressive language difficulties. An AAC evaluation can be completed by a speech-language pathologist who has expertise in this area. The evaluation will consider cognitive abilities and sensory impairments to determine the most appropriate form of communication. AAC devices can range from low-tech, such as picture exchange communication, to high-tech, such as voice-generating devices. Contrary to popular belief, AAC devices do not hinder verbal development of speech, and in many cases can improve it.</p></div></div><div id="ap4-def.Surveillance"><h3>Surveillance</h3><p>Patients should be evaluated periodically (i.e., every 6-12 months) by an interdisciplinary team that includes a neurologist, clinical geneticist, developmental specialist, orthopedic surgeon/physiatrist, physical therapist, occupational therapist, and speech and language pathologist to assess disease progression, maximize ambulation and communication skills, and reduce other manifestations (<a class="figpopup" href="/books/NBK535153/table/ap4-def.T.recommended_surveillance_for_i/?report=objectonly" target="object" rid-figpopup="figap4defTrecommendedsurveillancefori" rid-ob="figobap4defTrecommendedsurveillancefori">Table 6</a>).</p><div id="ap4-def.T.recommended_surveillance_for_i" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with AP-4 Associated Hereditary Spastic Paraplegia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK535153/table/ap4-def.T.recommended_surveillance_for_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ap4-def.T.recommended_surveillance_for_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ap4-def.T.recommended_surveillance_for_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_ap4-def.T.recommended_surveillance_for_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_ap4-def.T.recommended_surveillance_for_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency</th></tr></thead><tbody><tr><td headers="hd_h_ap4-def.T.recommended_surveillance_for_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_ap4-def.T.recommended_surveillance_for_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmologic evaluation for visual acuity &#x00026; need for support services for the visually impaired</td><td headers="hd_h_ap4-def.T.recommended_surveillance_for_i_1_1_1_3" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;">As needed</td></tr><tr><td headers="hd_h_ap4-def.T.recommended_surveillance_for_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastrointestinal/</b><br /><b>Feeding</b></td><td headers="hd_h_ap4-def.T.recommended_surveillance_for_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Aspiration risk &#x00026; nutritional status</div></li><li class="half_rhythm"><div>Monitor for constipation &#x00026; bowel dysfunction.</div></li></ul></td></tr><tr><td headers="hd_h_ap4-def.T.recommended_surveillance_for_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Pulmonary</b></td><td headers="hd_h_ap4-def.T.recommended_surveillance_for_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Monitor for aspiration &#x00026; pulmonary complications.</td></tr><tr><td headers="hd_h_ap4-def.T.recommended_surveillance_for_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Genitourinary</b></td><td headers="hd_h_ap4-def.T.recommended_surveillance_for_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Urodynamic testing</td></tr><tr><td headers="hd_h_ap4-def.T.recommended_surveillance_for_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_ap4-def.T.recommended_surveillance_for_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>PT/OT evaluation; assessment for contractures, scoliosis, &#x00026; foot deformities</div></li><li class="half_rhythm"><div>Hip/spine x-rays</div></li></ul></td><td headers="hd_h_ap4-def.T.recommended_surveillance_for_i_1_1_1_3" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;">Yearly; more frequently if needed</td></tr><tr><td headers="hd_h_ap4-def.T.recommended_surveillance_for_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_ap4-def.T.recommended_surveillance_for_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Monitor &#x00026; treat spasticity.</div></li><li class="half_rhythm"><div>Monitor those w/seizures as clinically indicated.</div></li></ul></td></tr><tr><td headers="hd_h_ap4-def.T.recommended_surveillance_for_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/</b><br /><b>Other</b></td><td headers="hd_h_ap4-def.T.recommended_surveillance_for_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Monitor developmental progress &#x00026; educational/family needs.</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">OT = occupational therapy; PT = physicial therapy</p></div></dd></dl></div></div></div></div><div id="ap4-def.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#ap4-def.Related_Genetic_Counseling_Issue">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="ap4-def.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="ap4-def.Genetic_Counseling"><h2 id="_ap4-def_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="ap4-def.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>AP-4-associated hereditary spastic paraplegia (HSP) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>AP4B1</i>, <i>AP4E1</i>, <i>AP4M1</i>, or <i>AP4S1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> To date, individuals with AP-4-associated HSP are not known to reproduce.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>AP4B1</i>, <i>AP4E1</i>, <i>AP4M1</i>, or <i>AP4S1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="ap4-def.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>AP4B1</i>, <i>AP4E1</i>, <i>AP4M1</i>, or <i>AP4S1</i> pathogenic variants in the family.</p></div><div id="ap4-def.Related_Genetic_Counseling_Issue"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="ap4-def.Prenatal_Testing_and_Preimplanta"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>AP4B1</i>, <i>AP4E1</i>, <i>AP4M1</i>, or <i>AP4S1</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="ap4-def.Resources"><h2 id="_ap4-def_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Cure AP-4, Inc.</b></div><div>24R Pleasant Street</div><div>Unit 2</div><div>Newburyport MA 01950</div><div><b>Email:</b> info@cureap4.org</div><div><a href="http://cureap4.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cureap4.org</a></div></li><li class="half_rhythm"><div><b>HSP Research Foundation</b></div><div>P.O. Box 4064</div><div>Warrimoo New South Wales NSW 2774</div><div>Australia</div><div><a href="https://www.hspersunite.org.au/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.hspersunite.org.au</a></div></li><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div>PO Box 5801</div><div>Bethesda MD 20824</div><div><b>Phone:</b> 800-352-9424 (toll-free); 301-496-5751; 301-468-5981 (TTY)</div><div><a href="https://www.ninds.nih.gov/Disorders/All-Disorders/Hereditary-Spastic-Paraplegia-Information-Page" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Hereditary Spastic Paraplegia Information Page</a></div></li><li class="half_rhythm"><div><b>Tom Wahlig-Foundation</b></div><div>Tom Wahlig Stiftung</div><div>B&#x000fc;ro Veghestrasse 22</div><div>Germany</div><div><b>Phone:</b> 49 (0) 251 - 20 07 91 20</div><div><b>Email:</b> nfo@hsp-info.de</div><div><a href="http://www.hsp-info.de/en/foundation.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.hsp-info.de/en/foundation.htm</a></div></li><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div>PO Box 5801</div><div>Bethesda MD 20824</div><div><b>Phone:</b> 800-352-9424 (toll-free); 301-496-5751; 301-468-5981 (TTY)</div><div><a href="https://www.ninds.nih.gov/Disorders/All-Disorders/Hereditary-Spastic-Paraplegia-Information-Page" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Hereditary Spastic Paraplegia Information Page</a></div></li><li class="half_rhythm"><div><b>Spastic Paraplegia Foundation, Inc.</b></div><div>7700 Leesburg Pike</div><div>Ste 123</div><div>Falls Church VA 22043</div><div><b>Phone:</b> 877-773-4483 (toll-free)</div><div><b>Email:</b> information@sp-foundation.org</div><div><a href="http://sp-foundation.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">sp-foundation.org</a></div></li></ul></div><div id="ap4-def.Molecular_Genetics"><h2 id="_ap4-def_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="ap4-def.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>AP-4-Associated Hereditary Spastic Paraplegia: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK535153/table/ap4-def.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ap4-def.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_ap4-def.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_ap4-def.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_ap4-def.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_ap4-def.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_ap4-def.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_ap4-def.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_ap4-def.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/10717" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>AP4B1</i></a></td><td headers="hd_b_ap4-def.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=10717" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1p13<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_ap4-def.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9Y6B7" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AP-4 complex subunit beta-1</a></td><td headers="hd_b_ap4-def.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_ap4-def.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=AP4B1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AP4B1</a></td><td headers="hd_b_ap4-def.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=AP4B1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AP4B1</a></td></tr><tr><td headers="hd_b_ap4-def.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/23431" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>AP4E1</i></a></td><td headers="hd_b_ap4-def.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=23431" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">15q21<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_ap4-def.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9UPM8" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AP-4 complex subunit epsilon-1</a></td><td headers="hd_b_ap4-def.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_ap4-def.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=AP4E1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AP4E1</a></td><td headers="hd_b_ap4-def.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=AP4E1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AP4E1</a></td></tr><tr><td headers="hd_b_ap4-def.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/9179" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>AP4M1</i></a></td><td headers="hd_b_ap4-def.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=9179" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">7q22<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_ap4-def.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O00189" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AP-4 complex subunit mu-1</a></td><td headers="hd_b_ap4-def.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/AP4M1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AP4M1 database</a></td><td headers="hd_b_ap4-def.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=AP4M1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AP4M1</a></td><td headers="hd_b_ap4-def.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=AP4M1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AP4M1</a></td></tr><tr><td headers="hd_b_ap4-def.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/11154" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>AP4S1</i></a></td><td headers="hd_b_ap4-def.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=11154" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">14q12</a></td><td headers="hd_b_ap4-def.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9Y587" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AP-4 complex subunit sigma-1</a></td><td headers="hd_b_ap4-def.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_ap4-def.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=AP4S1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AP4S1</a></td><td headers="hd_b_ap4-def.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=AP4S1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AP4S1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="ap4-def.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="ap4-def.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for AP-4-Associated Hereditary Spastic Paraplegia (<a href="/omim/602296,607243,607244,607245,612936,613744,614066,614067" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK535153/table/ap4-def.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ap4-def.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/602296" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">602296</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ADAPTOR-RELATED PROTEIN COMPLEX 4, MU-1 SUBUNIT; AP4M1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607243" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607243</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ADAPTOR-RELATED PROTEIN COMPLEX 4, SIGMA-1 SUBUNIT; AP4S1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607244" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607244</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ADAPTOR-RELATED PROTEIN COMPLEX 4, EPSILON-1 SUBUNIT; AP4E1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607245" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607245</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ADAPTOR-RELATED PROTEIN COMPLEX 4, BETA-1 SUBUNIT; AP4B1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/612936" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">612936</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/613744" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">613744</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614066" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614066</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614067" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614067</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE; SPG52</td></tr></tbody></table></div></div><div id="ap4-def.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>AP-4-associated hereditary spastic paraplegia (HSP) is caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in one of four genes (<i>AP4B1</i>, <i>AP4E1</i>, <i>AP4M1</i>, <i>AP4S1</i>) that encode subunits of the AP4 complex (&#x003b2;4, &#x003b5;, &#x003bc;4, &#x003c3;4, respectively). Loss of any one subunit renders the entire heterotetrameric complex nonfunctional; hence, <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants in any one of the four genes cause the same cellular outcome &#x02013; loss of AP-4 complex function [<a class="bk_pop" href="#ap4-def.REF.hirst.2013.153">Hirst et al 2013</a>, <a class="bk_pop" href="#ap4-def.REF.frazier.2016.400">Frazier et al 2016</a>]. Reduction or loss of the mutated subunit causes a reduction in the whole cell level of the other subunits as they are no longer able to be incorporated into a stable complex, and so are degraded by the cell. Evolutionary studies also support the obligate nature of the AP-4 complex because organisms either have all four AP-4 HSP-related genes or none at all [<a class="bk_pop" href="#ap4-def.REF.hirst.2013.153">Hirst et al 2013</a>].</p><p>The AP-4 complex is ubiquitously expressed in human tissues, including in the central nervous system [<a class="bk_pop" href="#ap4-def.REF.hirst.2013.153">Hirst et al 2013</a>]. At steady state, AP-4 localizes at the subcellular level to the <a class="def" href="/books/n/gene/glossary/def-item/trans/"><i>trans</i></a>-Golgi network (TGN), where it functions in the sorting of transmembrane cargo proteins into transport vesicles for TGN export. In AP-4-deficient cells these cargo proteins will be missorted and so will become mislocalized in the cell, likely affecting their function. A number of proteins have been suggested to be AP-4 cargo proteins. Evidence has emerged supporting a role for AP-4 in the post-Golgi trafficking of the autophagy protein ATG9A [<a class="bk_pop" href="#ap4-def.REF.ivankovic.2017">Ivankovic et al 2017</a>, <a class="bk_pop" href="#ap4-def.REF.mattera.2017.e10697">Mattera et al 2017</a>, <a class="bk_pop" href="#ap4-def.REF.davies.2018.3958">Davies et al 2018</a>, <a class="bk_pop" href="#ap4-def.REF.de_pace.2018.e1007363">De Pace et al 2018</a>].</p><div id="ap4-def.AP4B1"><h4><i>AP4B1</i></h4><p><b>Gene structure.</b> The predominant <i>AP4B1</i> transcript <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_006594.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_006594.4</a> consists of 11 exons. Alternatively spliced transcript variant that encode different <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> are known.</p><p>See <a href="/books/NBK535153/#ap4-def.molgen.TA">Table A</a>, <b>Gene</b> for a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, transcript, and protein information.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_006594.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_006594.4</a> transcript encodes the AP-4 complex subunit beta-1 (also known as &#x003b2;4) predicted to be 739 amino acids in length (<a href="https://www.ncbi.nlm.nih.gov/protein/NP_006585.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_006585.2</a>) [<a class="bk_pop" href="#ap4-def.REF.dellangelica.1999.7278">Dell'Angelica et al 1999</a>, <a class="bk_pop" href="#ap4-def.REF.hirst.1999.2787">Hirst et al 1999</a>]. The sequence of &#x003b2;4 is strongly conserved through evolution with orthologs in mammals and other vertebrates. &#x003b2;4 assembles into protein complex AP-4 (see <a href="#ap4-def.Molecular_Pathogenesis">Molecular Pathogenesis</a>). &#x003b2;4 domains include one involved in the assembly of the AP-4 complex, and a second that binds an accessory protein for AP-4 known as tepsin [<a class="bk_pop" href="#ap4-def.REF.frazier.2016.400">Frazier et al 2016</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Most <i>AP4B1</i> pathogenic variants identified to date predict truncation and/or destabilization of the protein, suggesting that pathogenicity results from loss of function of the &#x003b2;4 protein [<a class="bk_pop" href="#ap4-def.REF.ebrahimifakhari.2018.311">Ebrahimi-Fakhari et al 2018</a>].</p></div><div id="ap4-def.AP4E1"><h4><i>AP4E1</i></h4><p><b>Gene structure.</b> The <i>AP4E1</i> transcript <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007347.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_007347.4</a> consists of 21 exons. Alternatively spliced transcript variants that encode different <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> are known.</p><p>See <a href="/books/NBK535153/#ap4-def.molgen.TA">Table A</a>, <b>Gene</b> for a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007347.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_007347.4</a> transcript encodes the AP-4 complex subunit epsilon-1 (also known as &#x003b5;) predicted to be 1,137-amino acids in length (<a href="https://www.ncbi.nlm.nih.gov/protein/NP_031373.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_031373.2</a>) [<a class="bk_pop" href="#ap4-def.REF.dellangelica.1999.7278">Dell'Angelica et al 1999</a>, <a class="bk_pop" href="#ap4-def.REF.hirst.1999.2787">Hirst et al 1999</a>]. The sequence of &#x003b5; is strongly conserved through evolution with orthologs in mammals and other vertebrates. &#x003b5; assembles into protein complex AP-4 (see <a href="#ap4-def.Molecular_Pathogenesis">Molecular Pathogenesis</a>). &#x003b5; domains include one involved in the assembly of the AP-4 complex, and a second shown to bind an AP-4 accessory protein known as tepsin [<a class="bk_pop" href="#ap4-def.REF.mattera.2015.30736">Mattera et al 2015</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Most <i>AP4E1</i> pathogenic variants identified to date predict truncation and/or destabilization of the protein, suggesting that pathogenicity results from loss of function of the &#x003b5; protein [<a class="bk_pop" href="#ap4-def.REF.abou_jamra.2011.788">Abou Jamra et al 2011</a>].</p></div><div id="ap4-def.AP4M1"><h4><i>AP4M1</i></h4><p><b>Gene structure.</b> The <i>AP4M1</i> transcript <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_004722.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_004722.3</a> has 15 exons. There are multiple splice variants.</p><p>See <a href="/books/NBK535153/#ap4-def.molgen.TA">Table A</a>, <b>Gene</b> for a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The transcript <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_004722.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_004722.3</a> encodes AP-4 complex subunit mu-1 (also known as &#x000b5;4) predicted to be 453 amino acids in length (<a href="https://www.ncbi.nlm.nih.gov/protein/NP_004713.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_004713.2</a>) [<a class="bk_pop" href="#ap4-def.REF.dellangelica.1999.7278">Dell'Angelica et al 1999</a>, <a class="bk_pop" href="#ap4-def.REF.hirst.1999.2787">Hirst et al 1999</a>]. The sequence of &#x000b5;4 is strongly conserved through evolution with orthologs in mammals and other vertebrates. &#x000b5;4 assembles into protein complex AP-4 (see <a href="#ap4-def.Molecular_Pathogenesis">Molecular Pathogenesis</a>). The &#x000b5;4 domains include one that is involved in the assembly of the AP-4 complex, and a protein-protein interaction module known as a Mu homology <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> that in adaptor protein complexes binds to linear sorting motifs in transmembrane cargo proteins.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Most <i>AP4M1</i> pathogenic variants identified to date predict truncation and/or destabilization of the protein, suggesting that pathogenicity results from loss of function of the &#x000b5;4 protein [<a class="bk_pop" href="#ap4-def.REF.verkerk.2009.40">Verkerk et al 2009</a>].</p></div><div id="ap4-def.AP4S1"><h4><i>AP4S1</i></h4><p><b>Gene structure.</b>
<i>AP4S1</i> consists of six exons. There are multiple alternative splice variants encoding different protein <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a>.</p><p>See <a href="/books/NBK535153/#ap4-def.molgen.TA">Table A</a>, <b>Gene</b> for a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007077.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_007077.4</a> transcript encodes AP-4 complex subunit sigma-1 (also known as &#x003c3;4) predicted to be 159 amino acids in length (<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009008.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_009008.2</a>) [<a class="bk_pop" href="#ap4-def.REF.dellangelica.1999.7278">Dell'Angelica et al 1999</a>, <a class="bk_pop" href="#ap4-def.REF.hirst.1999.2787">Hirst et al 1999</a>]. The sequence of &#x003c3;4 is strongly conserved through evolution with orthologs in mammalians and other vertebrates. &#x003c3;4 assembles into a protein complex, named AP-4 (see <a href="#ap4-def.Molecular_Pathogenesis">Molecular Pathogenesis</a>). &#x003c3;4 has a 1-142 amino acid region that is involved in the assembly of the AP-4 complex.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Most <i>AP4S1</i> pathogenic variants identified to date predict truncation and/or destabilization of the protein, suggesting that pathogenicity results from loss of function of the &#x003c3;4 protein [<a class="bk_pop" href="#ap4-def.REF.abou_jamra.2011.788">Abou Jamra et al 2011</a>, <a class="bk_pop" href="#ap4-def.REF.hardies.2015.2218">Hardies et al 2015</a>].</p></div></div></div><div id="ap4-def.References"><h2 id="_ap4-def_References_">References</h2><div id="ap4-def.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="ap4-def.REF.abou_jamra.2011.788">Abou Jamra R, Philippe O, Raas-Rothschild A, Eck SH, Graf E, Buchert R, Borck G, Ekici A, Brockschmidt FF, N&#x000f6;then MM, Munnich A, Strom TM, Reis A, Colleaux L. Adaptor protein complex 4 deficiency causes severe autosomal-recessive intellectual disability, progressive spastic paraplegia, shy character, and short stature. <span><span class="ref-journal">Am J Hum Genet. </span>2011;<span class="ref-vol">88</span>:788–95.</span> [<a href="/pmc/articles/PMC3113253/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3113253</span></a>] [<a href="/pubmed/21620353" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21620353</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ap4-def.REF.davies.2018.3958">Davies AK, Itzhak DN, Edgar JR, Archuleta TL, Hirst J, Jackson LP, Robinson MS, Borner GHH. AP-4 vesicles contribute to spatial control of autophagy via RUSC-dependent peripheral delivery of ATG9A. <span><span class="ref-journal">Nat Commun. </span>2018;<span class="ref-vol">9</span>:3958.</span> [<a href="/pmc/articles/PMC6160451/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6160451</span></a>] [<a href="/pubmed/30262884" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30262884</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ap4-def.REF.de_pace.2018.e1007363">De Pace R, Skirzewski M, Damme M, Mattera R, Mercurio J, Foster AM, Cuitino L, Jarnik M, Hoffmann V, Morris HD, Han TU, Mancini GMS, Buonanno A, Bonifacino JS. Altered distribution of ATG9A and accumulation of axonal aggregates in neurons from a mouse model of AP-4 deficiency syndrome. <span><span class="ref-journal">PLOS Genetics. </span>2018;<span class="ref-vol">14</span>:e1007363.</span> [<a href="/pmc/articles/PMC5940238/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5940238</span></a>] [<a href="/pubmed/29698489" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29698489</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ap4-def.REF.dellangelica.1999.7278">Dell'Angelica EC, Mullins C, Bonifacino JS. AP-4, a novel protein complex related to clathrin adaptors. <span><span class="ref-journal">J Biol Chem. </span>1999;<span class="ref-vol">274</span>:7278–85.</span> [<a href="/pubmed/10066790" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10066790</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ap4-def.REF.ebrahimifakhari.2018.311">Ebrahimi-Fakhari D, Cheng C, Dies K, Diplock A, Pier DB, Ryan CS, Lanpher BC, Hirst J, Chung WK, Sahin M, Rosser E, Darras B, Bennett JT, et al.  Clinical and genetic characterization of AP4B1-associated SPG47. <span><span class="ref-journal">Am J Med Genet A. </span>2018;<span class="ref-vol">176</span>:311–8.</span> [<a href="/pubmed/29193663" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29193663</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ap4-def.REF.fink.2013.307">Fink JK. Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms. <span><span class="ref-journal">Acta Neuropathol. </span>2013;<span class="ref-vol">126</span>:307–28.</span> [<a href="/pmc/articles/PMC4045499/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4045499</span></a>] [<a href="/pubmed/23897027" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23897027</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ap4-def.REF.frazier.2016.400">Frazier MN, Davies AK, Voehler M, Kendall AK, Borner GH, Chazin WJ, Robinson MS, Jackson LP. Molecular basis for the interaction between AP4 beta4 and its accessory protein, tepsin. <span><span class="ref-journal">Traffic. </span>2016;<span class="ref-vol">17</span>:400–15.</span> [<a href="/pmc/articles/PMC4805503/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4805503</span></a>] [<a href="/pubmed/26756312" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26756312</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ap4-def.REF.hardies.2015.2218">Hardies K, May P, Dj&#x000e9;mi&#x000e9; T, Tarta-Arsene O, Deconinck T, Craiu D, Helbig I, Suls A, Balling R, Weckhuysen S, De Jonghe P, Hirst J, et al.  Recessive loss-of-function mutations in AP4S1 cause mild fever-sensitive seizures, developmental delay and spastic paraplegia through loss of AP-4 complex assembly. <span><span class="ref-journal">Hum Mol Genet. </span>2015;<span class="ref-vol">24</span>:2218–27.</span> [<a href="/pmc/articles/PMC4380070/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4380070</span></a>] [<a href="/pubmed/25552650" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25552650</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ap4-def.REF.hirst.1999.2787">Hirst J, Bright NA, Rous B, Robinson MS. Characterization of a fourth adaptor-related protein complex. <span><span class="ref-journal">Mol Biol Cell. </span>1999;<span class="ref-vol">10</span>:2787–802.</span> [<a href="/pmc/articles/PMC25515/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC25515</span></a>] [<a href="/pubmed/10436028" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10436028</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ap4-def.REF.hirst.2013.153">Hirst J, Irving C, Borner GH. Adaptor protein complexes AP-4 and AP-5: new players in endosomal trafficking and progressive spastic paraplegia. <span><span class="ref-journal">Traffic. </span>2013;<span class="ref-vol">14</span>:153–64.</span> [<a href="/pubmed/23167973" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23167973</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ap4-def.REF.ivankovic.2017">Ivankovic D, L&#x000f3;pez-Dom&#x000e9;nech G, Drew J, Tooze SA, Kittler JT. AP-4 mediated ATG9A sorting underlies axonal and autophagosome biogenesis defects in a mouse model of AP-4 deficiency syndrome. bioRxiv. 2017. Preprint available <a href="https://www.biorxiv.org/content/early/2017/12/16/235101" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. Accessed 9-17-19.</div></li><li class="half_rhythm"><div class="bk_ref" id="ap4-def.REF.marras.2016.436">Marras C, Lang A, van de Warrenburg BP, Sue CM, Tabrizi SJ, Bertram L, Mercimek-Mahmutoglu S, Ebrahimi-Fakhari D, Warner TT, Durr A, Assmann B, Lohmann K, Kostic V, Klein C. Nomenclature of genetic movement disorders: recommendations of the International Parkinson and Movement Disorder Society task force. <span><span class="ref-journal">Mov Disord. </span>2016;<span class="ref-vol">31</span>:436–57.</span> [<a href="/pubmed/27079681" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27079681</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ap4-def.REF.mattera.2015.30736">Mattera R, Guardia CM, Sidhu SS, Bonifacino JS. Bivalent motif-ear interactions mediate the association of the accessory protein tepsin with the AP-4 adaptor complex. <span><span class="ref-journal">J Biol Chem. </span>2015;<span class="ref-vol">290</span>:30736–49.</span> [<a href="/pmc/articles/PMC4692204/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4692204</span></a>] [<a href="/pubmed/26542808" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26542808</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ap4-def.REF.mattera.2017.e10697">Mattera R, Park SY, De Pace R, Guardia CM, Bonifacino JS. AP-4 mediates export of ATG9A from the trans-Golgi network to promote autophagosome formation. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2017;<span class="ref-vol">114</span>:E10697–706.</span> [<a href="/pmc/articles/PMC5740629/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5740629</span></a>] [<a href="/pubmed/29180427" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29180427</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ap4-def.REF.morenodeluca.2011.141">Moreno-De-Luca A, Helmers SL, Mao H, Burns TG, Melton AM, Schmidt KR, Fernhoff PM, Ledbetter DH, Martin CL. Adaptor protein complex-4 (AP-4) deficiency causes a novel autosomal recessive cerebral palsy syndrome with microcephaly and intellectual disability. <span><span class="ref-journal">J Med Genet. </span>2011;<span class="ref-vol">48</span>:141–4.</span> [<a href="/pmc/articles/PMC3150730/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3150730</span></a>] [<a href="/pubmed/20972249" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20972249</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ap4-def.REF.raza.2015.715">Raza MH, Mattera R, Morell R, Sainz E, Rahn R, Gutierrez J, Paris E, Root J, Solomon B, Brewer C, Basra MA, Khan S, Riazuddin S, Braun A, Bonifacino JS, Drayna D. Association between rare variants in AP4E1, a component of intracellular trafficking, and persistent stuttering. <span><span class="ref-journal">Am J Hum Genet. </span>2015;<span class="ref-vol">97</span>:715–25.</span> [<a href="/pmc/articles/PMC4667129/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4667129</span></a>] [<a href="/pubmed/26544806" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26544806</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ap4-def.REF.roubertie.2018.e217">Roubertie A, Hieu N, Roux CJ, Leboucq N, Manes G, Charif M, Echenne B, Goizet C, Guissart C, Meyer P, Marelli C, Rivier F, Burglen L, Horvath R, Hamel CP, Lenaers G. AP4 deficiency: a novel form of neurodegeneration with brain iron accumulation? <span><span class="ref-journal">Neurol Genet. </span>2018;<span class="ref-vol">4</span>:e217.</span> [<a href="/pmc/articles/PMC5820597/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5820597</span></a>] [<a href="/pubmed/29473051" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29473051</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ap4-def.REF.verkerk.2009.40">Verkerk AJ, Schot R, Dumee B, Schellekens K, Swagemakers S, Bertoli-Avella AM, Lequin MH, Dudink J, Govaert P, van Zwol AL, Hirst J, Wessels MW, Catsman-Berrevoets C, Verheijen FW, de Graaff E, de Coo IF, Kros JM, Willemsen R, Willems PJ, van der Spek PJ, Mancini GM. Mutation in the AP4M1 gene provides a model for neuroaxonal injury in cerebral palsy. <span><span class="ref-journal">Am J Hum Genet. </span>2009;<span class="ref-vol">85</span>:40–52.</span> [<a href="/pmc/articles/PMC2706965/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2706965</span></a>] [<a href="/pubmed/19559397" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19559397</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ap4-def.REF.vill.2017.797">Vill K, M&#x000fc;ller-Felber W, Alhaddad B, Strom TM, Teusch V, Weigand H, Blaschek A, Meitinger T, Haack TB. A homozygous splice variant in AP4S1 mimicking neurodegeneration with brain iron accumulation. <span><span class="ref-journal">Mov Disord. </span>2017;<span class="ref-vol">32</span>:797–9.</span> [<a href="/pubmed/28150420" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28150420</span></a>]</div></li></ul></div></div><div id="ap4-def.Chapter_Notes"><h2 id="_ap4-def_Chapter_Notes_">Chapter Notes</h2><div id="ap4-def.Author_Notes"><h3>Author Notes</h3><p>Please visit:</p><p><a href="http://www.CureSPG47.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><b>www.CureSPG47.org</b></a> to learn about ongoing research on AP-4-associated hereditary spastic paraplegia. Current research includes an International Registry and Natural History Study that is open for enrollment.</p><p><a href="http://www.childrenshospital.org/conditions-and-treatments/conditions/s/spastic-paraplegia-47" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><b>AP-4-HSP Program at the Translational Neuroscience Center</b></a><br />Boston Children's Hospital<br />300 Longwood Avenue<br />Boston, Massachusetts 02115<br />Email: darius.ebrahimi-fakhari@childrens.harvard.edu</p></div><div id="ap4-def.Acknowledgments"><h3>Acknowledgments</h3><p>The authors are grateful to the CureSPG47 organization (<a href="http://www.CureSPG47.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.CureSPG47.org</a>) for endorsing and supporting their research on AP-4 deficiency.</p></div><div id="ap4-def.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>13 December 2018 (bp) Review posted live</div></li><li class="half_rhythm"><div>21 June 2018 (def) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK535153</span><span class="label">PMID: <a href="/pubmed/30543385" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">30543385</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ano5-md/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/fap/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK535153&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK535153/?report=reader">PubReader</a></li><li><a href="/books/NBK535153/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK535153" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK535153" style="display:none" title="Cite this Page"><div class="bk_tt">Ebrahimi-Fakhari D, Behne R, Davies AK, et al. AP-4-Associated Hereditary Spastic Paraplegia. 2018 Dec 13. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK535153/pdf/Bookshelf_NBK535153.pdf">PDF version of this page</a> (490K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#ap4-def.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#ap4-def.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#ap4-def.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#ap4-def.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#ap4-def.Genetically_Related_Allelic_Diso" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#ap4-def.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#ap4-def.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#ap4-def.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#ap4-def.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#ap4-def.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#ap4-def.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#ap4-def.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=9179[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">AP4M1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=11154[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">AP4S1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=23431[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">AP4E1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=10717[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">AP4B1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4678786" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4678786" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4678786" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4678786" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30869852" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> FARS2 Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> FARS2 Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Almannai M, Faqeih E, El-Hattab AW, Wong LJC. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31525725" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Generation and characterization of six human induced pluripotent stem cell lines (iPSC) from three families with AP4B1-associated hereditary spastic paraplegia (SPG47).</a><span class="source">[Stem Cell Res. 2019]</span><div class="brieflinkpop offscreen_noflow">Generation and characterization of six human induced pluripotent stem cell lines (iPSC) from three families with AP4B1-associated hereditary spastic paraplegia (SPG47).<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Teinert J, Behne R, D'Amore A, Wimmer M, Dwyer S, Chen T, Buttermore ED, Chen IP, Sahin M, Ebrahimi-Fakhari D. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Stem Cell Res. 2019 Oct; 40:101575. Epub 2019 Sep 11.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29300443" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> RAB18 Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> RAB18 Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Handley M, Sheridan E. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24781758" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">An AP4B1 frameshift mutation in siblings with intellectual disability and spastic tetraplegia further delineates the AP-4 deficiency syndrome.</a><span class="source">[Eur J Hum Genet. 2015]</span><div class="brieflinkpop offscreen_noflow">An AP4B1 frameshift mutation in siblings with intellectual disability and spastic tetraplegia further delineates the AP-4 deficiency syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Abdollahpour H, Alawi M, Kortüm F, Beckstette M, Seemanova E, Komárek V, Rosenberger G, Kutsche K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur J Hum Genet. 2015 Feb; 23(2):256-9. Epub 2014 Apr 30.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29193663" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Clinical and genetic characterization of AP4B1-associated SPG47.</a><span class="source">[Am J Med Genet A. 2018]</span><div class="brieflinkpop offscreen_noflow">Clinical and genetic characterization of AP4B1-associated SPG47.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ebrahimi-Fakhari D, Cheng C, Dies K, Diplock A, Pier DB, Ryan CS, Lanpher BC, Hirst J, Chung WK, Sahin M, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Med Genet A. 2018 Feb; 176(2):311-318. Epub 2017 Nov 28.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=30543385" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=30543385" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc8b52dd21425a25c63762">AP-4-Associated Hereditary Spastic Paraplegia - GeneReviews®</a><div class="ralinkpop offscreen_noflow">AP-4-Associated Hereditary Spastic Paraplegia - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T03:50:26-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE8900D5DFC856E10000000002F70166&amp;ncbi_session=CE8900D5DFC8B521_0759SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK535153%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK535153&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK535153/&amp;ncbi_pagename=AP-4-Associated Hereditary Spastic Paraplegia - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8900D5DFC8B521_0759SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>